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Background: Mansonella ozzardi is a poorly understood human filarial parasite with a broad distribution throughout
Latin America. Most of what is known about its parasitism has come from epidemiological studies that have estimated
parasite incidence using light microscopy. Light microscopy can, however, miss lighter, submicroscopic, infections. In this
study we have compared M. ozzardi incidence estimates made using light microscopy, with estimates made using PCR.
Methods: 214 DNA extracts made from Large Volume Venous Blood Samples (LVVBS) were taken from volunteers from
two study sites in the Rio Solimões region: Codajás [n = 109] and Tefé [n = 105] and were subsequently assayed for
M. ozzardi parasitism using a diagnostic PCR (Mo-dPCR). Peripheral finger-prick blood samples were taken from the same
individuals and used for microscopic examination. Finger-prick blood, taken from individuals from Tefé, was also used for
the creation of FTA®card dried blood spots (DBS) that were subsequently subjected to Mo-dPCR.
Results: Overall M. ozzardi incidence estimates made with LVVBS PCRs were 1.8 times higher than those made using
microscopy (44.9 % [96/214] compared with 24.3 % [52/214]) and 1.5 times higher than the PCR estimates made from
FTA®card DBS (48/105 versus 31/105). PCR-based detection of FTA®card DBS proved 1.3 times more sensitive at
diagnosing infections from peripheral blood samples than light microscopy did: detecting 24/105 compared with
31/105. PCR of LVVBS reported the fewest number of false negatives, detecting: 44 of 52 (84.6 %) individuals diagnosed
by microscopy; 27 of 31 (87.1 %) of those diagnosed positive from DBSs and 17 out of 18 (94.4 %) of those diagnosed
as positive by both alternative methodologies.
Conclusions: In this study, Mo-dPCR of LVVBS was by far the most sensitive method of detecting M. ozzardi infections
and detected submicroscopic infections. Mo-dPCR FTA®card DBS also provided a more sensitive test for M. ozzardi
diagnosis than light microscopy based diagnosis did and thus in settings where only finger-prick assays can be
carried-out, it may be a more reliable method of detection. Most existing M. ozzardi incidence estimates, which are often
based on light microscope diagnosis, are likely to dramatically underestimate true M. ozzardi parasitism incidence levels.
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Mansonella ozzardi is a New World human filarial para-
site that is broadly distributed throughout Central and
South America. Locally acquired M. ozzardi infections
have been reported in a diverse range of communities
throughout Latin America, spanning from Mexico (in the
north) to Argentina (in the south) [1]. Parasite incidence
surveys have shown population parasitism levels in excess
of 15 % in multiple Caribbean islands, Argentina, Bolivia,
and numerous geographically diffuse localities within the
Brazilian Amazon [2–8].
Together with its African relatives (M. perstans and
M. streptocerca), M. ozzardi is one of three aetiological
agents that causes human mansonelliasis [9, 10]. While
many symptoms have been attributed to the mansonel-
liasis condition, there is presently no universally agreed
symptom-set used for its clinical diagnosis [1, 9, 10].
Despite the fact that some of these attributed pathologies
are quite disabling, the perception that mansonelliasis is
mostly benign, seems to be the most prevalently held view
by international policy makers. Certainly, the condition is
not presently the subject of any major international or even
national control programmes and is not presently regarded
by the World Health Organisation (WHO) as one of the
world’s 17 most Neglected Tropical Diseases [11].
Whether or not this general perception of Mansonelliasis
as benign is justified, there is undoubtedly a strong and
growing case that M. ozzardi parasitism in the Amazon re-
gion is of more medical importance than it is elsewhere.
As well as the continuing problems concerning the dis-
crimination of O. volvulus and M. ozzardi parasites and
also exposure to these parasites in the Amazonia onchocer-
ciasis focus [12–14], there is also a growing body of
evidence to suggest that M. ozzardi infections can them-
selves directly cause articular pain, headaches, and in the
Brazilian Amazon even that they can cause ocular lesions
[2, 15]. Interest in how M. ozzardi parasitism may be
affecting other parasitic infections, such as malaria, is also
growing [4, 16–18]. The number of epidemiological stud-
ies, designed to detect correlations between the clinical
presentation of symptoms of Mansonella parasite infec-
tions and behavioural risk factors associated with them, is
thus rising [2, 5–7]. Fundamental to the success of all such
studies is accurate diagnosis of parasitism, which for
M. ozzardi, is traditionally done using light microscopy.
Molecular studies of other insect-borne blood parasites,
such as malaria, have shown that incidence estimates
based on microscopy alone can dramatically underesti-
mate the true levels of parasitism in a population [19–21].
Typically, in malaria parasitism incidence studies, light
microscopy will predict incidence levels half those pre-
dicted when PCR and microscopy are used in combin-
ation [19–21]. Most experts attribute the differences
between the incidence estimates largely to differences insensitivities between the two techniques: with microscopy
only detecting heavy infections and PCR detecting both
heavy and lighter (submicroscopic) infections. One
Malaria expert has, for example, estimated that a good
microscopist has a parasite detection threshold of about
40–50 parasites per micro litre, whereas PCR can be ex-
pected to routinely detect parasite densities lower than
one parasite per micro litre [22].
In the study presented here we have set out to assess if
light-microscope based diagnosis of M. ozzardi is under-
reporting true M. ozzardi incidence levels and to collect
data that may help improve the specificity and sensitivity
of M. ozzardi diagnosis in the future. To achieve our
objectives, we have used PCR and light-microscopy to
diagnose the infection-status of 214 individuals in a
M. ozzardi endemic region of the Brazilian Amazon. In
a 105-person sub-sample of these individuals we have
PCR-tested both a frozen venous blood-sample and a
finger-prick FTA®card dried blood-spot as a way of
assessing the best practice for sample preservation. By
comparing the diagnoses made by the variously trialled
parasite-detection methodologies, our study has revealed
a very high incidence of submicroscopic M. ozzardi
infections in the Brazilian Amazon and has provided
important base-line data from which new more effective
M. ozzardi diagnostic techniques may be developed.
Methods
Study site selection
Very high levels of M. ozzardi parasitism have been re-
corded throughout the Brazilian Amazon region, but the
Rio Solimões region e.g. Coari, Codajás, and Tefé region
is one of only a few regions where high M. ozzardi inci-
dence measurements and ocular pathologies have been
recorded [7, 13]. In this study, blood samples were taken
from two study sites around the Rio Solimões, referred
to here as: (I) Tefé and (ii) Codajás. In each rural com-
munity, all residents were invited to participate voluntar-
ily in the study. Volunteers who participated at the Tefé
study-site arm of the study were from settlements close
to Tefé. Participants from the Codajás study site were
from settlements flanking the Rio Solimões between the
towns of Codajás and Coari (see Fig. 1).
Blood sampling
Blood samples were taken in one of two ways: peripheral
blood was taken by digital finger puncture; venous blood
samples were collected using a BD™ Vacuntainer system.
Blood samples were collected from volunteers from the
two study areas, following the procedure set out by the
Research Ethical Committee of the Tropical Medicine
Foundation Dr Heitor Vieira Dourado (in Manaus proto-
col 1504/10). Venous blood samples (of approximately
10 ml) were initially stored with EDTA at temperatures
Fig. 1 A map showing the location of the Tefé and Codajás localities used in this study. Amazonas state is shown inside of continental South
America. These two study areas are shaded in grey and labelled appropriately; the Rio Solimões is shown in red
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before molecular processing. The thick blood smear
preparations that were used for light microscopic parasite
diagnosis were performed with peripheral blood samples
shortly after the samples were taken. Dried Blood Spots
(DBS) were also prepared from peripheral blood samples,
but were only taken from the 105 volunteers from the
Tefé study site.
Light-microscopic detection of M. ozzardi infections
Light microscopy M. ozzardi diagnosis was performed
on fresh peripheral blood samples obtained by finger
punctures. Thick blood smears were made as previously
described by Medeiros et al. [7].PCR detection of M. ozzardi infections
Mansonella ozzardi diagnostic PCRs (Mo-dPCRs) were
carried-out following the amplification and band-scoring
methodology detailed in Tang et al. [23]. As before, 5 μl
of template DNA was used in an initial 50 μl PCR reac-
tion mix; however, in this study the assayed template
DNA was prepared slightly differently. For the large vol-
ume venous blood samples (LVVBS), the assayed DNA
was derived from a 200 μl QIAGEN extract prepared
using a QIAGEN blood and tissue extraction kit and
protocol and an initial 100 μl of venous blood sample.
For the Dried blood spots Mo-dPCRs, the initial tem-
plate DNA was derived from a 150 μl Chelex®100-extract
obtained from 20 (1.2 mm diameter) discs taken from a
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FTA®cards. Each volunteer’s 20 FTA®card discs samples
were processed simultaneously using the manufacturer’s
FTA®card neutralising solution and protocol. Processed
discs were then incubated with 150 μl of 5 % Chelex®100
solution at 56 °C for 30 minutes and then at 100 °C for
10 minutes. A sample of 20M. ozzardi positive samples
were confirmed as such by forward and reverse Sanger
sequencing using a methodology based on that described
by Tang et al. [23].
All PCRs were performed alongside negative and posi-
tive controls. Mansonella ozzardi positive DNA prepara-
tions used in Tang et al. [23] were used in this study as
positive controls. Negative controls were prepared with
the template DNA being replaced by sterilised Millipore
water and blood extract from volunteers whose blood had
already repeatedly tested negative on previous microscope
and PCR testing. Mansonella ozzardi PCR negative DNA
preparations that tested positive for M. ozzardi in one or
more other assays, were tested for the existence of amplifi-
able human DNA with routinely-used house-keeping gene
primers, which specifically amplify the human β-actin
gene [24]. FTA®card discs were cut using a Harris® 1.2 mm
micro-punch instrument, with discs cut from blank areas
of FTA®cards between DBS samples. These blank discs
were also processed with FTA®card neutralising fluid and
Chelex®100-extraction and served as further negative con-
trols. These negative controls tested for Harris® micro-
punch carry-over sample contamination.
Results
Mansonella ozzardi and only M. ozzardi parasitism was
detected by both traditional light microscopy and PCRTable 1 Sensitivity estimates for three M. ozzardi blood parasite de
Parasitism reference standard Venous blood ModPCR
Samples testing positive with the venous
blood ModPCR assay
Samples testing positive with dried blood
spot MoPCR assay
27/31 (87.1 %) [105]
Samples testing positive with the light
microscopy assay
21/24 (87.5 %) [105]
44/52 (84.6 %) [214]
Samples testing positives with any other assay 31/37 (83.8 %) [105]
54/65 (83.1 %) [214]
Sample testing positives with both other assays 17/18 (94.4 %) [105]
Samples testing positive with all three assays 47/53 (88.7 %) [105]
96/107 (89.7 %) [214]
Assay sensitivity-estimate ranges 83.1 %–94.4 %
Table 1 shows sensitivity estimates for three M. ozzardi blood parasite detection ass
parasitism reference standards (as indicated). The number of blood samples which
brackets. Estimates are divided into: (i) those based solely on data obtained from in
for which 105 blood samples were assessed and (ii) the total datasets, which comb
blood samples assessed)at both study sites. Sequences of PCR products used for
parasite diagnosis confirmed the existence of the parasite
at both sites and found no evidence to support the exist-
ence of other filariae. All DNA preparations that tested
positive in their first PCR assay also tested positive in
their repeated PCR assay and no evidence of Harris®
micro-punch carry-over was detected from the carry-
over negative controls.
Table 1 shows a suite of sensitivity estimates calculated
for each of the tested M. ozzardi diagnostic assays. A
total of five sensitivity calculations have been made for
each of the tested assays. Each of the five different sensi-
tivity calculations assume a different method of defining
whether a sample is truly positive or not (as indicated in
Table 1). Regardless of which methodology is used as a
reference “gold standard” of M. ozzardi infection, the
PCR assay of LVVBS is calculated to be the most sensi-
tive method of diagnosis. The lowest sensitivity estimate
for this assay that we calculated was 83.1 % and the
highest was 94.4 %. The 83.1 % sensitivity estimate for
LVVBS-PCR diagnosis was calculated on the basis that
an individual is indeed “truly positive” if they tested
positive by any other method of diagnosis. All of the
diagnostic tests assessed in the study using this defin-
ition of a “true positive” produce conservative sensitivity
estimates (Table 1). This is because this method of esti-
mating sensitivity is most likely to detect an assay’s false-
negative reporting. It is, however, also the method most
likely to underestimate an assay’s true sensitivity, as it is
also the calculation most likely to over-estimate the
number of “true positives” in a sample (because it ne-
glects the possibility that other diagnostic assays could
be generating false-positives).tection assays
assay Dried blood spot MoPCR assay Light microscopy assay
27/47 (57.4 %) [105] 21/47 (44.7 %) [105]
44/96 (45.8 %) [214]
18/31 (58.1 %) [105]
18/24 (75 %) [105]
28/50 (56 %) [105] 24/52 (46.2 %) [105]
47/101 (46.5 %) [214]
17/21 (81 %) [105] 17/27 (63 %) [105]
31/53 (58.5 %) [105] 24/53 (45.3 %) [105]
52/107 (48.6 %) [214]
56 %–81 % 44.7 %–63 %
ays. Sensitivity calculations have been made using six different blood
had test results included for the sensitivity estimates is given in square
dividuals from Tefé (for which data was obtained using all three assays) and
ines the data from Codajás with the Tefé data (for which there was a total 214
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mates that we calculated are higher than some of the
DBS ModPCR estimates, the sensitivity estimates that
we made for DBS were always higher than the directly
comparable estimates for light microscopy made using
the same reference standard for what is a “truly” infected
individual (Table 1). Our study data thus strongly sup-
port the notion that PCR based diagnosis (performed on
DBS or LVVBS) is a lot more sensitive than microscopy
based diagnosis of thick blood smears.
It is important to note, however, that all three assays
used to diagnose M. ozzardi infections provided strong
evidence of reporting false negatives (Table 1). Even if the
most stringent conditions of what is a “truly positive” indi-
vidual is assumed and thus that only those testing positive
with two or more assays are regarded as “truly positive”,
all three methods of diagnosis can be seen to have
reported false negatives (Table 1). Although, our results
suggest that LVVBS is substantially more sensitive than
thick blood smear methods of light microscopy diagnosis,
in its present form at least, it should not properly be
regarded as a true gold standard of diagnosis. As we also
have no reason to suspect that any of our diagnosed posi-
tives are false positives, these calculations only serve to
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Table 2 shows M. ozzardi summary prevalence estimates for the Rio Solimões as a w
into infections that were detected (patent) in light microscopy and infections that w
sub-microscopic infections. Additionally, the table shows a breakdown of sub-micro
methods. Corresponding calculations based on each assay's submicroscopic parasit
microscopy (LM) false negatives and prevalence underestimating for M. ozzardi par
blood spot is abbreviated to DBS and venous blood to VBlight microscopy to estimate M. ozzardi parasitism popu-
lation incidence levels.
In terms of understanding of M. ozzardi epidemiology
in the Rio Solimões region, overall incidence rates almost
doubled with the inclusion of PCR-based diagnosed indi-
viduals from 52 out of 214 volunteers (24.3 %), (based on
light microscopy alone) to 100 out of the same 214
(46.7 %) volunteers when both light microscopy and PCR
diagnoses were combined, showing a 1.92 fold increase in
incidence estimates (Table 2). Underlying this was a very
large number of individuals that tested positive only by
PCR-based methods of diagnosis. Such sub-patent or sub-
microscopic infections accounted for 48 of the 214 volun-
teers (22.4 %) of all those diagnosed as M. ozzardi infected
(Table 2). At both study sites, and using both LVVBS, and
DBS, our analysis detected more parasite positive samples
using the PCR based diagnosis method than by using the
light microscopy based method (Table 2). Overall parasit-
ism incidence estimates for the Rio Solimões region can
be increased by 1.85 times if LVVBS ModPCR is used as
the method of diagnosis instead of light microscopy:
LVVBS ModPCR estimated incidence levels of 44.9 % in
contrast to the 24.3 % incidence estimates made using
light microscopy from the same volunteers (Table 2).
ModPCR also managed to detect 1.29 times moreegion
Rio Solimões combined data
105 (44.8 %) 96/214 (44.9 %)
105 (29.5 %)
% (24/105) 24.3 % (52/214)
ModPCR: 24.8 %(26/105) VB-ModPCR: 22.4 % (48/214)
-ModPCR: 11.4 %(12/105) DBS or VB ModPCR: 23.8 % (51/214)
or VB ModPCR: 27.6 %(29/105)
ModPCR: 47.6 % (50/105) VB-ModPCR: 46.7 % (100/214)
-ModPCR: 34.3 % (36/105) DBS or VB ModPCR: 48.6 % (104/214)
or VB ModPCR: 51.4 % (54/105)
ModPCR: ≥32.1 % (≥26/81) VB-ModPCR: 2.08
-ModPCR: ≥14.8 % (≥12/81) DBS-ModPCR: 1.5
or VB ModPCR:≥35.8 % (≥29/81) DBS or VB ModPCR: 2.25
ModPCR: 2.08 × VB-ModPCR:1.92 ×
-ModPCR: 1.5 × DBS or VB ModPCR: 2 ×
or VB ModPCR: 2.25 ×
hole and divided by the two study areas. Estimates are also shown divided
ere not detected by light microscopy, but were detected by PCR:
scopic parasite detection and prevalence estimates made by different assaying
e detection have also been used to estimate the minimum number of light
asite infections. All calculations neglect the possibility of false positives. Dried
Medeiros et al. Parasites & Vectors  (2015) 8:280 Page 6 of 8parasitized individuals than light microscopy did for the
same set of 105 volunteers from Tefé (Table 2), suggesting
it is a more sensitive technique than light microscopy
based diagnosis used in isolation.
Discussion
In this study we have shown thatM. ozzardi parasitism in-
cidence estimates in the Rio Solimões region, made using
light microscopy-based diagnosis in isolation, are about
half those made using the method in combination with
ModPCR assays. A similar under-reporting of sub-patent
or submicroscopic blood parasite infections has been de-
scribed for malaria infection diagnosis in a diverse range
malaria endemic settings [16–18]. It seems likely that the
light microscope M. ozzardi parasitism incidence underes-
timations made in this study are typical of light micros-
copy based M. ozzardi parasitism surveys. As most
existing M. ozzardi incidence estimates (and indeed other
Mansonella parasitism incidence estimates) are based on
light microscope diagnosis, most M. ozzardi incidence es-
timates are therefore likely to be gross underestimates of
true levels of M. ozzardi parasitism incidence levels in the
Amazon region and in other areas beyond [2–8].
Mansonelliasis parasitism caused by M. perstans in
Africa has been calculated to be affecting 114 million
people [25]. These estimates have been made on the basis
of ~20 % incidence levels (a value typical of M. perstans
light microscopy incidence surveys) [25]. To our know-
ledge, no such global estimates of M. ozzardi parasitism
have been recently calculated; however, incidence mea-
surements of about 20 % are typical of traditional light-
microscopy surveys and are in-line with what we have
observed. Hopefully, our results will ensure that if such
M. ozzardi global estimates are made in future they will
take into account submicroscopic infections and by doing
so could potentially double estimates made solely from
light microscopy incidence surveys alone. In a recent
Global Burden of Disease (GBD) survey, which uses
disease pathology, and incidence to estimate the public
health impact of disease, Mansonelliasis infections were
not listed among the 291 catalogued diseases that had
their global impact assessed [26]. This is probably because
Mansonelliasis is often regarded as completely benign
and/or because the pathologies that have been attributed
to Mansonella infections are so poorly defined, making
meaningful calculations of the burden of Mansonelliasis
presently infeasible. Our results suggest, however, that if
Mansonelliasis does have a clinical pathology and is
included in a future global burden study, it could be seen
to have a much greater burden than would have been pro-
jected from traditional blood-smear based light-microscopy
diagnosis alone.
Most of the risk factors and clinical symptoms that have
previously been attributed to M. ozzardi infections havecome from epidemiological studies that have reported
co-incidences of infections and volunteers’ sex, age and/or
reported symptoms, and/or demographics [2, 5, 7, 15].
Similar surveys have, however, often reported conflicting
results and as things stand the only undisputed medical
significance of M. ozzardi parasites and their infections is
that they can be confused with O. volvulus parasites and
their infections and that this can interfere with onchocer-
ciasis research and control [1, 12, 23]. Our results show
that many of the individuals diagnosed as negative using
light microscopy are in fact positive, but positive with sub-
patent submicroscopic infections. If Mansonelliasis does
have a clinically important pathology, our results could
help to explain why M. ozzardi parasitism has remained
so ill-defined. For example, it is well understood (from
extensive light microscopy diagnosed infection surveys)
that the levels of patent M. ozzardi infections can vary
dramatically across space and time [2, 5–7]. Thus it is
possible that submicroscopic infections vary similarly (but
asynchronously with respect to patent infections) and that
the incongruence between similar M. ozzardi epidemio-
logical studies, may be explained by simple inconsistent
levels of misdiagnosis in epidemiological surveying.
Mansonella ozzardi epidemiological surveys using both
light microscopy and ModPCRs in combination thus offer
the possibility to re-evaluate the clinical importance of
M. ozzardi. It is also clear from this work that combining
light microscopy and ModPCR provides the potential to
make a convenient subdivision between light levels of
parasitism (submicroscopic infections) and heavy levels of
parasitism (microscopically patent) as is already carried
out in Malaria research [19–22]. This could potentially
help make the clinical symptoms of the infections as well
as the risk factors for contracting the parasites become
more salient.
From a technical perspective, our study showed that
the Tang et al. [23] ModPCR assay used in this study is
more sensitive for parasite detection than light micros-
copy alone― even when only small peripheral finger-
prick blood samples are available. DNA preparations
made from 100 μl LVVBS were shown in this study to
be substantially more effective at detecting parasite in-
fections than the alternative tested methods (Table 1).
There is, however, little doubt that this approach was
also missing true positives, that is to say individuals
infected with M. ozzardi. The LVVBS ModPCR assay
should not therefore be regarded as a true gold standard,
even though our data suggests it is the best reported
assay for detecting M. ozzardi parasitism.
Blood samples are notorious for containing PCR inhibi-
tors and so it is unlikely that ModPCR tested in this study
can be expected to identify all truly positive individuals
[27]. However, in the case of this study PCR inhibitors are
unlikely to account for our “false negative” results as all of
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amplified from them, showing both that the DNA extrac-
tion procedure in the sample processing had worked and
that PCR inhibitors were absent or in limited quantities.
Our results thus suggest that there is scope for both of
our ModPCRs-based assays to be improved.
In previous parasite assaying studies, increasing the total
amount of starting whole blood used to prepare a DNA
extract for PCR detection was shown to increase the as-
say’s sensitivity [27]. Consistent with this, the LVVBS assay
used in this study contained more starting DNA than the
DBS PCRs and also showed higher sensitivity. Although
the differences in our study findings might also be
explained by differences in pre-processing methodologies,
both the preservation methodologies used in this study
are routinely used methods for preserving DNA for PCR.
It thus seems likely that the sensitivity of both assays
could be improved by increasing the volume of whole
blood used in the assay extraction procedures. In other
studies of parasitism diagnosis techniques, the sensitivity
of the assays has been shown to be increased without the
need to sample more initial staring material by, for
example, the lysis of parasites prior to their application to
FTA®cards [27]. Because most of the proven methods of
liberating DNA from microfilariae (which have tough cuti-
cles) involve processes that are not easily performed in a
field setting (like, for example, laser-dissection, and liquid-
nitrogen freeze-thawing), the most practical ways of
improving the sensitivity of ModPCR-based M. ozzardi
diagnosis techniques, are thus likely to be achieved by
assaying larger volumes of whole blood [28].
While other ModPCRs could be trialled to improve M.
ozzardi diagnosis, none of the existing published methods
have yet been validated to the extent of the Tang et al.
method [23]. Some of the published M. ozzardi PCR
assays, for example, still need to be tested on field mater-
ial, while others still need to show the PCR products they
amplify are indeed of M. ozzardi origin [29, 30]. As there
is presently no reason to be believe that the Tang et al.
[21] ModPCR used in this study is reporting false-
positives or false-negatives (when M. ozzardi DNA is
available to amplify), it appears to us that, at this stage at
least, M. ozzardi diagnostics will improve most rapidly if
ModPCR-based diagnosis continues to focus on its use.
Conclusions
In this study, the ModPCR performed on LVVBS was by
far the most sensitive method of detecting M. ozzardi in-
fections and detected high-levels of submicroscopic infec-
tions. ModPCR detection of M. ozzardi parasites preserved
within FTA®card DBS also provided a more sensitive test
for M. ozzardi diagnosis than light microscopy, in situa-
tions where only finger-prick assays can be carried-out,
it maybe be a more reliable method of detection. Mostexisting M. ozzardi incidence estimates, which are often
based on light microscope diagnosis, are likely to be
dramatically underestimating true M. ozzardi parasitism
incidence levels. Both types of ModPCR assays tested in
this study could potentially be improved by increasing the
amount of whole blood starting material. Future ModPCR-
based epidemiological studies could potentially give a more
clear picture of true global M. ozzardi incidence levels and
shed more light on the clinical symptoms of Mansonelliasis
infections and also the risk factors associated with them.
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